Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Basking Ridge, New Jersey
- Most recent report
- 8-K, filed Oct 14, 2026
- Incorporated
- Delaware
- Filings on record
- 1,001+ filings
- On EDGAR
- CIK 320017
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 71
News 8 of 217
Prospectuses and Registrations 8 of 82
- S-8 Registration statement for an employee plan Jan 8, 2026
- 424B5 Prospectus supplement for an offering Aug 21, 2024
- S-8 Registration statement for an employee plan Jul 15, 2024
- S-3 Shelf registration statement May 1, 2024
- S-8 Registration statement for an employee plan Jul 13, 2023
- S-8 Registration statement for an employee plan Oct 17, 2022
- 424B5 Prospectus supplement for an offering Sep 26, 2022
- 424B3 Prospectus supplement for an offering Jul 29, 2022
Proxies 8 of 42
- DEF 14A Proxy statement for a shareholder vote Oct 19, 2026
- PRE 14A Preliminary proxy statement Oct 7, 2026
- DEFA14A Extra proxy material Apr 25, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2025
- DEFA14A Extra proxy material Apr 29, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2024
- DEFA14A Extra proxy material May 1, 2023
- DEF 14A Proxy statement for a shareholder vote May 1, 2023
Ownership 8 of 488
- 3 Insider reported their initial holding Oct 15, 2026
- 3 Insider reported their initial holding Sep 28, 2026
- 3 Insider reported their initial holding Sep 28, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 26, 2026
- 4 Insider reported a trade Jan 13, 2026
- 4 Insider reported a trade Jan 13, 2026
- 4 Insider reported a trade Jan 13, 2026
- 4 Insider reported a trade Jan 13, 2026
Other 8 of 101
Everything here comes from Lisata Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.